Octadentate Zirconium(IV)-Loaded Macrocycles with Varied Stoichiometry Assembled From Hydroxamic Acid Monomers using Metal-Templated Synthesis

Inorganic Chemistry

Volumn 56, Issue 6, 2017, Pages 3719-3728

  Tieu, William ^a   Lifa, Tulip ^a   Katsifis, Andrew ^b   Codd, Rachel ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; COORDINATION COMPOUND; HYDROXAMIC ACID; LIGAND; MACROCYCLIC COMPOUND; ZIRCONIUM;

CHEMICAL STRUCTURE; CHEMISTRY; DIAGNOSTIC IMAGING; MOLECULAR MODEL; NEOPLASM; POSITRON EMISSION TOMOGRAPHY; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

CHELATING AGENTS; COORDINATION COMPLEXES; CRYSTALLOGRAPHY, X-RAY; HYDROXAMIC ACIDS; LIGANDS; MACROCYCLIC COMPOUNDS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; ZIRCONIUM;

EID: 85015765015     PISSN: 00201669     EISSN: 1520510X     Source Type: Journal    
DOI: 10.1021/acs.inorgchem.7b00362     Document Type: Article

References (65)

1. Price, E. W.; Orvig, C. Matching chelators to radiometals for radiopharmaceuticals Chem. Soc. Rev. 2014, 43, 260-290 10.1039/C3CS60304K
2. Zeglis, B. M.; Houghton, J. L.; Evans, M. J.; Viola-Villegas, N.; Lewis, J. S. Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals Inorg. Chem. 2014, 53, 1880-1899 10.1021/ic401607z
3. Price, T. W.; Greenman, J.; Stasiuk, G. J. Current advances in ligand design for inorganic positron emission tomography tracers 68Ga, 64Cu, 89Zr and 44Sc Dalton Trans. 2016, 45, 15702-15724 10.1039/C5DT04706D
4. Boros, E.; Marquez, B. V.; Ikotun, O. F.; Lapi, S. E.; Ferreira, C. L. In Ligand Design in Medicinal Inorganic Chemistry; Storr, T., Ed.; John Wiley and Sons, Ltd: Chichester, UK, 2014.
5. 89Zr, a radiometal nuclide with high potential for molecular imaging with PET: chemistry, applications and remaining challenges Molecules 2013, 18, 6469-6490 10.3390/molecules18066469
6. Blower, P. J. A nuclear chocolate box: the periodic table of nuclear medicine Dalton Trans. 2015, 44, 4819-4844 10.1039/C4DT02846E
7. Brasse, D.; Nonat, A. Radiometals: towards a new success story in nuclear imaging Dalton Trans. 2015, 44, 4845-4858 10.1039/C4DT02911A
8. van Dongen, G. A. M. S.; Huisman, M. C.; Boellaard, R.; Hendrikse, N. H.; Windhorst, A. D.; Visser, G. W. M.; Molthoff, C. F. M.; Vugts, D. J. 89Zr-immuno-PET for imaging of long circulating drugs and disease targets: why, how and when to be applied? Q. J. Nucl. Med. Mol. Imaging 2015, 59, 18-38
9. Scharli, R. K.; Price, R. I.; Chan, S.; Cryer, D.; Jeffery, C. M.; Asad, A. H.; Morandeau, L.; Eu, P.; Cullinane, C.; Kasbollah, A.; Katsifis, A. Establishing reliable production of the PET isotope 89Zr for research use: From target fabrication to preclinical imaging AIP Conf. Proc. 2012, 1509, 101-107 10.1063/1.4773949
10. 89Zr-labeled monoclonal antibodies J. Nucl. Med. 2003, 44, 1271-1281
11. Rice, S. L.; Roney, C. A.; Daumar, P.; Lewis, J. A. The next generation of positron emission tomography radiopharmaceuticals in oncology Semin. Nucl. Med. 2011, 41, 265-282 10.1053/j.semnuclmed.2011.02.002
12. Deri, M. A.; Zeglis, B. M.; Francesconi, L. C.; Lewis, J. S. PET imaging with 89Zr: From radiochemistry to the clinic Nucl. Med. Biol. 2013, 40, 3-14 10.1016/j.nucmedbio.2012.08.004
13. n Inorg. Chem. 1997, 36, 737-739 10.1021/ic960987z
14. Baroncelli, F.; Grossi, G. The complexing power of hydroxamic acids and its effect on the behaviour of organic extractants in the reprocessing of irradiated fuels. I. The complexes between benzohydroxamic acid and zirconium, iron(III) and uranium(IV) J. Inorg. Nucl. Chem. 1965, 27, 1085-1092 10.1016/0022-1902(65)80420-1
15. 89Zr(IV) complexation with hydroxamates: progress towards designing a better chelator than desferrioxamine B for immuno-PET imaging Chem. Commun. 2013, 49, 1002-1004 10.1039/C2CC37549D
16. Codd, R. Traversing the coordination chemistry and chemical biology of hydroxamic acids Coord. Chem. Rev. 2008, 252, 1387-1408 10.1016/j.ccr.2007.08.001
17. Hider, R. C.; Kong, X. Chemistry and biology of siderophores Nat. Prod. Rep. 2010, 27, 637-657 10.1039/b906679a
18. Braich, N.; Codd, R. Immobilized metal affinity chromatography for the capture of hydroxamate-containing siderophores and other Fe(III)-binding metabolites from bacterial culture supernatants Analyst 2008, 133, 877-880 10.1039/b802355g
19. Ejje, N.; Soe, C. Z.; Gu, J.; Codd, R. The variable hydroxamic acid siderophore metabolome of the marine actinomycete Salinispora tropica CNB-440 Metallomics 2013, 5, 1519-1528 10.1039/c3mt00230f
20. Meijs, W. E.; Herscheid, J. D. M.; Haisma, H. J.; Pinedo, H. M. Evaluation of desferal as a bifunctional chelating agent for labeling antibodies with Zr-89 Appl. Radiat. Isot. 1992, 43, 1443-1447 10.1016/0883-2889(92)90170-J
21. Meijs, W. E.; Haisma, H. J.; Klok, R. P.; van Gog, F. B.; Kievit, E.; Pinedo, H. M.; Herscheid, J. D. Zirconium-labeled monocloncal antibodies and their distribution in tumor-bearing nude mice J. Nucl. Med. 1997, 38, 112-118
22. Börjesson, P. K. E.; Jauw, Y. W. S.; Boellaard, R.; de Bree, R.; Comans, E. F. I.; Roos, J. C.; Castelijns, J. A.; Vosjan, M. J. W. D.; Kummer, J. A.; Leemans, C. R.; Lammertsma, A. A.; van Dongen, G. A. M. S. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients Clin. Cancer Res. 2006, 12, 2133-2140 10.1158/1078-0432.CCR-05-2137
23. van Rij, C. M.; Sharkey, R. M.; Goldenberg, D. M.; Frielink, C.; Molkenboer, J. D.; Franssen, G. M.; van Weerden, W. M.; Oyen, W. J.; Boerman, O. C. Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EPG-1 monoclonal antibody J. Nucl. Med. 2011, 52, 1601-1607 10.2967/jnumed.110.086520
24. 89Zr-trastuzumab for HER2/neu imminoPET imaging J. Nucl. Med. 2009, 50, 974-981 10.2967/jnumed.108.060392
25. 89Zr-DFO-trastuzumab PLoS One 2010, 5, e8859 10.1371/journal.pone.0008859
26. Petrik, M.; Zhai, C.; Novy, Z.; Urbanek, L.; Haas, H.; Decristoforo, C. In vitro and in vivo comparison of selected Ga-68 adn Zr-89 labelled siderophores Mol. Imaging Biol. 2016, 18, 344-352 10.1007/s11307-015-0897-6
27. Jauw, Y. W. S.; Menke-van der Houven van Oordt, C. W.; Hoekstra, O. S.; Hendrikse, N. H.; Vugts, D. J.; Zijlstra, J. M.; Huisman, M. C.; van Dongen, G. A. M. S. Immuno-positron emission tomography with zirconium-89-labeled monoclonal antibodies in oncology: waht can we learn from initial clinical trials? Front. Pharmacol. 2016, 7 ( 131 ) 15 10.3389/fphar.2016.00131
28. Holland, J. P.; Vasdev, N. Charting the mechanism and reactivity of zirconium oxalate with hydroxamate ligands using density functional theory: Implications in new chelate design Dalton Trans. 2014, 43, 9872-9884 10.1039/c4dt00733f
29. 89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo J. Nucl. Med. 2010, 51, 1293-1300 10.2967/jnumed.110.076174
30. 89Zr in mice Nucl. Med. Biol. 2011, 38, 675-681 10.1016/j.nucmedbio.2010.12.011
31. Nayak, T. K.; Garmestani, K.; Milenic, D. E.; Brechbiel, M. W. PET and MRI of metastatic peritoneal and pulmonary colorectal cancer in mice with human epidermal growth factor receptor 1-targeted 89Zr-labeled panitumumab J. Nucl. Med. 2012, 53, 113-120 10.2967/jnumed.111.094169
32. Patra, M.; Bauman, A.; Mari, C.; Fischer, C. A.; Blacque, O.; Haussinger, D.; Gasser, G.; Mindt, T. L. An octadentate bifunctional chelating agent for the development of stable zirconium-89 based molecular imaging probes Chem. Commun. 2014, 50, 11523-11525 10.1039/C4CC05558F
33. Vugts, D. J.; Klaver, C.; Sewing, C.; Poot, A. J.; Adamzek, K.; Huegli, S.; Mari, C.; Visser, G. W. M.; Valverde, I. E.; Gasser, G.; Mindt, T. L.; van Dongen, G. A. M. S. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89-Zr-immuno-PET Eur. J. Nucl. Med. Mol. Imaging 2017, 44, 286-295 10.1007/s00259-016-3499-x
34. Kadi, N.; Oves-Costales, D.; Barona-Gomez, F.; Challis, G. L. A new family of ATP-dependent oligomerization-macrocyclization biocatalysts Nat. Chem. Biol. 2007, 3, 652-656 10.1038/nchembio.2007.23
35. Soe, C. Z.; Codd, R. Unsaturated macrocyclic dihydroxamic acid siderophores produced by Shewanella putrefaciens using precursor-directed biosynthesis ACS Chem. Biol. 2014, 9, 945-956 10.1021/cb400901j
36. Telfer, T. J.; Gotsbacher, M. P.; Soe, C. Z.; Codd, R. Mixing up the pieces of the desferrioxamine B jigsaw defines the biosynthetic sequence catalyzed by DesD ACS Chem. Biol. 2016, 11, 1452-1462 10.1021/acschembio.6b00056
37. Richardson-Sanchez, T.; Tieu, W.; Codd, R. Reverse biosynthesis: Generating combinatorial pools of drug leads from enzyme-mediated fragmentation of natural products ChemBioChem 2017, 18, 368-373 10.1002/cbic.201600636
38. 89Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3,-(LI-1,2-HOPO) J. Med. Chem. 2014, 57, 4849-4860 10.1021/jm500389b
39. 4+: Comparison with desferrioxamine B Dalton Trans. 2015, 44, 4884-4900 10.1039/C4DT02978J
40. Deri, M. A.; Ponnala, S.; Kozlowski, P.; Burton-Pye, B. P.; Cicek, H. T.; Hu, C.; Lewis, J. S.; Francesconi, L. C. p-SCN-Bn-HOPO: a superior bifunctional chelator for 89Zr immunoPET Bioconjugate Chem. 2015, 26, 2579-2591 10.1021/acs.bioconjchem.5b00572
41. Rudd, S. E.; Roselt, P.; Cullinane, C.; Hicks, R. J.; Donnelly, P. S. A desferrioxmaine B squaramide ester for the incorporation of zirconium-89 into antibodies Chem. Commun. 2016, 52, 11889-11892 10.1039/C6CC05961A
42. Guérard, F.; Lee, Y.-S.; Brechbiel, M. W. Rational design, synthesis, and evaluation of tetrahydroxamic acid chelators for stable complexation of zirconium(IV) Chem.-Eur. J. 2014, 20, 5584-5591 10.1002/chem.201304115
43. Boros, E.; Holland, J. P.; Kenton, N.; Rotile, N. J.; Caravan, P. Macrocycle-based hydroxamate ligands for complexation and immunoconjugation of 89zirconium for positron emission tomography (PET) imaging ChemPlusChem 2016, 81, 274-281 10.1002/cplu.201600003
44. McMurry, T. J.; Raymond, K. N.; Smith, P. H. Molecular recognition and metal ion template synthesis Science 1989, 244, 938-943 10.1126/science.2658057
45. McMurry, T. J.; Rodgers, S. J.; Raymond, K. N. Template and stepwise synthesis of a macrobicyclic catechoylamide ferric ion sequestering agent J. Am. Chem. Soc. 1987, 109, 3451-3453 10.1021/ja00245a042
46. Kachadourian, R.; Chuilon, S.; Mérienne, C.; Kunesch, G.; Deroussent, A. A New Total Synthesis of Ferrioxamine E through Metal-templated Cyclic Trimerization Supramol. Chem. 1997, 8, 301-308 10.1080/10610279708034949
47. Lifa, T.; Tieu, W.; Hocking, R. K.; Codd, R. Forward and reverse (retro) iron(III)-or gallium(III)-desferrioxamine E and ring-expanded analogs prepared using metal-templated synthesis from endo-hydroxamic acid monomers Inorg. Chem. 2015, 54, 3573-3583 10.1021/acs.inorgchem.5b00141
48. Giordanetto, F.; Kihlberg, J. Macrocyclic drugs and clinical candidates: What can medicinal chemists learn from their properties? J. Med. Chem. 2014, 57, 278-294 10.1021/jm400887j
49. Driggers, E. M.; Hale, S. P.; Lee, J.; Terrett, N. K. The exploration of macrocycles for drug discovery-an underexploited structural class Nat. Rev. Drug Discovery 2008, 7, 608-624 10.1038/nrd2590
50. Marsault, E.; Peterson, M. L. Macrocycles are great cycles: Applications, opportunities, and challenges of synthethic macrocycles in drug discovery J. Med. Chem. 2011, 54, 1961-2004 10.1021/jm1012374
51. Heinis, C. Drug discovery. Tools and rules for macrocycles Nat. Chem. Biol. 2014, 10, 696-698 10.1038/nchembio.1605
52. Marti-Centelles, V.; Pandey, M. D.; Burguete, M. I.; Luis, S. V. Macrocyclization reactions: the importance of conformational, configurational, and template-induced preorganisation Chem. Rev. 2015, 115, 8736-8834 10.1021/acs.chemrev.5b00056
53. Marti-Centelles, V.; Burguete, M. I.; Luis, S. V. Macrocycle synthesis by chloride-templated amide bond formation J. Org. Chem. 2016, 81, 2143-2147 10.1021/acs.joc.5b02676
54. Feistner, G. J.; Stahl, D. C.; Gabrik, A. H. Proferrioxamine siderophores of Erwinia amylovora. A capillary liquid chromatographic/electrospray tandem mass spectrometric study Org. Mass Spectrom. 1993, 28, 163-175 10.1002/oms.1210280307
55. Nishio, T.; Tanaka, N.; Hiratake, J.; Katsube, Y.; Ishida, Y.; Oda, J. Isolation and structure of the novel dihydroxamate siderophore alcaligin J. Am. Chem. Soc. 1988, 110, 8733-8734 10.1021/ja00234a045
56. Takahashi, A.; Nakamura, H.; Kameyama, T.; Kurasawa, S.; Naganawa, H.; Okami, Y.; Takeuchi, T.; Umezawa, H.; Iitaka, Y. Bisucaberin, a new siderophore, sensitizing tumor cells to macrophage-mediated cytolysis. II. Physico-chemical properties and structure determination J. Antibiot. 1987, 40, 1671-1676 10.7164/antibiotics.40.1671
57. Ledyard, K. M.; Butler, A. Structure of putrebactin, a new dihydroxamate siderophore produced by Shewanella putrefaciens JBIC, J. Biol. Inorg. Chem. 1997, 2, 93-97 10.1007/s007750050110
58. Soe, C. Z.; Pakchung, A. A. H.; Codd, R. Directing the biosynthesis of putrebactin or desferrioxamine B in Shewanella putrefaciens through the upstream inhibition of ornithine decarboxylase Chem. Biodiversity 2012, 9, 1880-1890 10.1002/cbdv.201200014
59. Boettcher, T.; Clardy, J. A chimeric siderophore halts swarming Vibrio Angew. Chem., Int. Ed. 2014, 53, 3510-3513 10.1002/anie.201310729
60. Soe, C. Z.; Telfer, T. J.; Levina, A.; Lay, P. A.; Codd, R. Simultaneous biosynthesis of putrebactin, avaroferrin and bisucaberin by Shewanella putrefaciens and characterisation of complexes with iron(III), molybdenum(VI) or chromium(V) J. Inorg. Biochem. 2016, 162, 207-215 10.1016/j.jinorgbio.2015.12.008
61. Dhungana, S.; White, P. S.; Crumbliss, A. L. Crystal structure of ferrioxamine B: A comparative analysis and implications for molecular recognition JBIC, J. Biol. Inorg. Chem. 2001, 6, 810-818 10.1007/s007750100259
62. Bergeron, R. J.; McManis, J. S. The total synthesis of desferrioxamines E and G Tetrahedron 1990, 46, 5881-5888 10.1016/S0040-4020(01)87913-8
63. Bergeron, R. J.; McManis, J. S.; Phanstiel, O. I.; Vinson, J. R. T. A versatile synthesis of deferrioxamine B J. Org. Chem. 1995, 60, 109-114 10.1021/jo00106a022
64. Wencewicz, T. A.; Oliver, A. G.; Miller, M. J. Iron(III)-templated macrolactonization of trihydroxamate siderophores Org. Lett. 2012, 14, 4390-4393 10.1021/ol301869x
65. Patiny, L.; Borel, A. ChemCalc: a building block for tomorrow’s chemical infrastructure J. Chem. Inf. Model. 2013, 53, 1223-1228 10.1021/ci300563h